期刊文献+

Anisodamine Inhibits Endotoxin-induced Tissue Factor Expression in Human Endothelial Cells

Anisodamine Inhibits Endotoxin-induced Tissue Factor Expression in Human Endothelial Cells
下载PDF
导出
摘要 By study on the effect of anisodamine on lipopolysaccharide- induced expression of tissue factor(TF) in vascular endothelial cells(EC) ,the mechanism of anisodam ine antithrom bosis,as well as in the treatm ent of bacteraemic shock was investigated.Human umbilical vein endothelial cells (HUVECs) were cultured by trypsin digestion m ethod.TF activity was measured in the lysates of HUVEC by using a single step clotting assay.Specific m RNA expression was detected by Northern blotting.In order to evaluate a possible contribution of the nuclear factor (NF) -κB pathway on the effects observed,electrophoretic mobility shift assays(EMSA) were performed using nuclear extracts from HU VECs and NF- κB- binding oligonucleotides.The results showed that treatment of HUVEC with L PS resulted in a significant increase in TF activity.Anisodamine dose- dependently inhibited L PS- induced upregulation of TF.These effects was also confirm ed on the level of specific TF m RNA expression by Northern blotting.Furtherm ore,EMSA showed that anisodamine com pletely abolished L PS- induced NF-κB DNA binding activity in nuclear ex- tracts from HUVECs treated with L PS together with anisodamine.The results suggest thataniso- damine counteracts endothelial cell activation by inhibiting L PS- induced TF expression in these cells.Its interference with the NF- κB pathway might- at least in part- contribute to this effect. The ability of anisodamine to counteract L PS effect on endothelial cells m ight be one underlying m echanism explaining its antithrombosis and efficacy in the treatment of bacteraemic shock. By study on the effect of anisodamine on lipopolysaccharide- induced expression of tissue factor(TF) in vascular endothelial cells(EC) ,the mechanism of anisodam ine antithrom bosis,as well as in the treatm ent of bacteraemic shock was investigated.Human umbilical vein endothelial cells (HUVECs) were cultured by trypsin digestion m ethod.TF activity was measured in the lysates of HUVEC by using a single step clotting assay.Specific m RNA expression was detected by Northern blotting.In order to evaluate a possible contribution of the nuclear factor (NF) -κB pathway on the effects observed,electrophoretic mobility shift assays(EMSA) were performed using nuclear extracts from HU VECs and NF- κB- binding oligonucleotides.The results showed that treatment of HUVEC with L PS resulted in a significant increase in TF activity.Anisodamine dose- dependently inhibited L PS- induced upregulation of TF.These effects was also confirm ed on the level of specific TF m RNA expression by Northern blotting.Furtherm ore,EMSA showed that anisodamine com pletely abolished L PS- induced NF-κB DNA binding activity in nuclear ex- tracts from HUVECs treated with L PS together with anisodamine.The results suggest thataniso- damine counteracts endothelial cell activation by inhibiting L PS- induced TF expression in these cells.Its interference with the NF- κB pathway might- at least in part- contribute to this effect. The ability of anisodamine to counteract L PS effect on endothelial cells m ight be one underlying m echanism explaining its antithrombosis and efficacy in the treatment of bacteraemic shock.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2002年第4期273-275,共3页 华中科技大学学报(医学英德文版)
基金 This projectwas supported byagrantfrom National Natu-ral Sciences Foundation of China (No. 39730 2 2 0 ) andWuhan Chenguang Program (No. 985 0 0 30 86)
关键词 ANISODAMINE endothelial cell tissue factor LIPOPOLYSACCHARIDE shock nuclear fac- tor-κB Anisodamine endothelial cell tissue factor lipopolysaccharide shock nuclear fac- tor-κB
  • 相关文献

参考文献11

  • 1阮秋蓉,宋建新,邓仲端,瞿智玲,倪娟.山莨菪碱下行调节培养的内皮细胞表达纤溶酶原激活物抑制剂1[J].中国动脉硬化杂志,2001,9(3):194-197. 被引量:10
  • 2Cybulsky M I,Chan M K W,Movat H Z.Acute inflammation and microthrombosis induced by endotoxin,interleukin-1, and tumor necrosis factor and their implication in gram-negative infection[].Laboratory Investigation.1988
  • 3Colucci M,Paramo J A,Collen D.Generation in plasma of a fast acting inhibitor of plasminogen activator in response to endotoxin stimulation[].The Journal of Clinical Investigation.1985
  • 4Colucci M,Balconi R,Corenzet R et al.Cultured human endothelial cells generate tissue factor in response to endotoxin[].The Journal of Clinical Investigation.1983
  • 5Parker M M,Parillo J E.Septic shock: Hemodynamics and pathogenesis[].The Journal of The American Medical Association.1983
  • 6Pober J S,Cotran R S.Cytokines and endothelial activation[].Physiological Reviews.1990
  • 7Collins T.Endothelial nuclear factor -kappa B and the initiation of the atherosclerotic lesion[].Laboratory Investigation.1993
  • 8Greeman R L,Schein R M,Martin M A et al.A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis[].The Journal of The American Medical Association.1991
  • 9Shubin H,Weil M H.Bacterial shock[].The Journal of The American Medical Association.1976
  • 10Su J Y.Cell protection mechanism of antishock action of anisodamine[].Chinese Medical Journal.1992

二级参考文献8

  • 1[1]Loskutoff DJ. Regulation of PAI-1 gene expression [J]. Fibrinolysis, 1991,5: 197-202
  • 2[2]Held C, Hjemdahl P, Rehnqvist N, et al. Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metroprolol:results from the angina prognosis study in Stockholm [J]. Circulation, 1997, 95: 2 380-386
  • 3[3]Iwai N, Shimoike H, Nakamura Y, et al. The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes [J]. Atherosclerosis, 1998, 136: 109-114
  • 4[6]Schneiderman J, Sawdey MS, Keeton MR, et al. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries [J]. Proc Natl Acad Sci USA, 1992, 89: 6 998-7 002
  • 5[7]Kohler HP, Grant PJ.Mechanisms of disease: plasminogen-activator inhibitor type 1 and coronary artery disease [J]. N Engl J Med, 2000, 342: 1 792-801
  • 6[8]Collins T.Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion [J]. Lab Invest, 1993, 68: 499-508
  • 7阮秋蓉,宋建新,邓仲端.川芎嗪抗血栓形成的机制研究[J].中国动脉硬化杂志,1998,6(4):297-300. 被引量:56
  • 8阮秋蓉,邓仲端.培养的人脐静脉内皮细胞产生单核细胞趋化因子的研究[J].中华病理学杂志,1991,20(3):205-208. 被引量:15

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部